Zhanqiang Li

764 total citations
52 papers, 520 citations indexed

About

Zhanqiang Li is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Zhanqiang Li has authored 52 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 10 papers in Physiology. Recurrent topics in Zhanqiang Li's work include Pulmonary Hypertension Research and Treatments (17 papers), Eicosanoids and Hypertension Pharmacology (10 papers) and High Altitude and Hypoxia (8 papers). Zhanqiang Li is often cited by papers focused on Pulmonary Hypertension Research and Treatments (17 papers), Eicosanoids and Hypertension Pharmacology (10 papers) and High Altitude and Hypoxia (8 papers). Zhanqiang Li collaborates with scholars based in China and United States. Zhanqiang Li's co-authors include Shanshan Su, Dianxiang Lu, Ri‐Li Ge, Dejun Zhang, Lan Ma, Yue‐Hu Pei, Gang Chen, Liyan Xue, Heng Chen and Fan Yang and has published in prestigious journals such as Journal of Materials Chemistry A, Inorganic Chemistry and Molecules.

In The Last Decade

Zhanqiang Li

46 papers receiving 511 citations

Peers

Zhanqiang Li

PRM

GENET

CCM

PHYSI

Dianxiang Lu China

Sheng Yao China

Zhiqin Wu China

Chuan Zhang China

Zeliang Wei China

Zhichen Pu China

Yanzhuo Liu China

Minmin Zhang China

Rong Yan China

Qiong He China

Dianxiang Lu China

Zhanqiang Li

212 ×1.5

131 ×1.1

PRM

91 ×1.2

GENET

71 ×1.2

CCM

61 ×1.2

PHYSI

Citations per year, relative to Zhanqiang Li Zhanqiang Li (= 1×) peers Dianxiang Lu

Countries citing papers authored by Zhanqiang Li

Since Specialization

Citations

This map shows the geographic impact of Zhanqiang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhanqiang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhanqiang Li more than expected).

Fields of papers citing papers by Zhanqiang Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhanqiang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhanqiang Li. The network helps show where Zhanqiang Li may publish in the future.

Co-authorship network of co-authors of Zhanqiang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zhanqiang Li. A scholar is included among the top collaborators of Zhanqiang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhanqiang Li. Zhanqiang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hou, Bin, Shanshan Su, Lei Ji, et al.. (2025). Luteolin alleviates right ventricular hypertrophy in high altitude pulmonary hypertension rats by regulating PI3K/AKT/mTOR signalling pathway. European Journal of Pharmacology. 1003. 177898–177898.

Luo, Yongming, et al.. (2025). Rhodiola tangutica (maxim.) S. H. Fu protects blood-retinal barrier in hypoxia-induced retinal injury rats by down-regulating HIF-1α/eNOS/NO pathway. Journal of Ethnopharmacology. 353(Pt A). 120325–120325. 1 indexed citations

Zhang, Zhaoxia, Chen Ju, Shanshan Su, et al.. (2024). Luteolin ameliorates hypoxic pulmonary vascular remodeling in rat via upregulating KV1.5 of pulmonary artery smooth muscle cells. Phytomedicine. 132. 155840–155840. 5 indexed citations

Wang, Jinyu, et al.. (2024). Echinacoside inhibits PASMCs calcium overload to prevent hypoxic pulmonary artery remodeling by regulating TRPC1/4/6 and calmodulin. Open Medicine. 19(1). 20241044–20241044. 2 indexed citations

Su, Shanshan, et al.. (2023). 4-Terpineol attenuates pulmonary vascular remodeling via suppressing PI3K/Akt signaling pathway in hypoxia-induced pulmonary hypertension rats. Toxicology and Applied Pharmacology. 473. 116596–116596. 3 indexed citations

Zhang, Meng, Zhanqiang Li, Huiming Xiang, et al.. (2023). High-entropy (Sm0.2Eu0.2Gd0.2Dy0.2Er0.2)2Hf2O7 ceramic with superb resistance to radiation-induced amorphization. Journal of Material Science and Technology. 155. 1–9. 20 indexed citations

Su, Shanshan, et al.. (2023). Kaempferol ameliorates pulmonary vascular remodeling in chronic hypoxia-induced pulmonary hypertension rats via regulating Akt-GSK3β-cyclin axis. Toxicology and Applied Pharmacology. 466. 116478–116478. 9 indexed citations

Su, Shanshan, et al.. (2022). The Mechanism of Volatile Oil of Rhodiola tangutica against Hypoxia‐Induced Pulmonary Hypertension in Rats Based on RAS Pathway. BioMed Research International. 2022(1). 9650650–9650650. 6 indexed citations

Li, Yujin, et al.. (2022). Using untargeted metabolomics to profile the differences of the fruits of Lycium barbarum in different geographical origins. Analytical Sciences. 38(8). 1083–1093. 6 indexed citations

10.

Yang, Mei, et al.. (2022). Mechanism of Traditional Tibetan Medicine Grubthobrildkr Alleviated Gastric Ulcer Induced by Acute Systemic Hypoxia in Rats. BioMed Research International. 2022(1). 4803956–4803956. 3 indexed citations

11.

Zhou, Yi, Zhanqiang Li, Dejun Zhang, & Benyin Zhang. (2021). Screening of bioactive ingredients of Tsantan Sumtang in ameliorating H9c2 cells injury. Journal of Ethnopharmacology. 285. 114854–114854. 7 indexed citations

12.

Su, Shanshan, et al.. (2021). Tsantan Sumtang Restored Right Ventricular Function in Chronic Hypoxia-Induced Pulmonary Hypertension Rats. Frontiers in Pharmacology. 11. 607384–607384. 16 indexed citations

13.

Zhang, Ruixia, Zhanqiang Li, Chuanchuan Liu, et al.. (2021). Pretreatment with the active fraction of Rhodiola tangutica (Maxim.) S.H. Fu rescues hypoxia-induced potassium channel inhibition in rat pulmonary artery smooth muscle cells. Journal of Ethnopharmacology. 283. 114734–114734. 6 indexed citations

14.

Zhang, Xiaoyan, et al.. (2020). Cognitive Protective Mechanism of Crocin Pretreatment in Rat Submitted to Acute High‐Altitude Hypoxia Exposure. BioMed Research International. 2020(1). 3409679–3409679. 22 indexed citations

15.

Su, Shanshan, et al.. (2019). Tsantan Sumtang attenuated chronic hypoxia-induced right ventricular structure remodeling and fibrosis by equilibrating local ACE-AngII-AT1R/ACE2-Ang1-7-Mas axis in rat. Journal of Ethnopharmacology. 250. 112470–112470. 67 indexed citations

16.

Su, Shanshan, Xiaodong Ma, Ximeng Wang, et al.. (2018). Bioactive fraction of Rhodiola algida against chronic hypoxia-induced pulmonary arterial hypertension and its anti-proliferation mechanism in rats. Journal of Ethnopharmacology. 216. 175–183. 37 indexed citations

17.

Wang, Xiaoxia, et al.. (2016). Urban Logistics under the Internet. WHICEB. 46. 1 indexed citations

18.

Zhang, Wei, Tana Wuren, Yaping Wang, et al.. (2015). Echinacoside induces rat pulmonary artery vasorelaxation by opening the NO-cGMP-PKG-BKCa channels and reducing intracellular Ca2+ levels. Acta Pharmacologica Sinica. 36(5). 587–596. 21 indexed citations

19.

Su, Shanshan, Aihua Song, Gang Chen, et al.. (2014). Two new indole-diterpenoids from the fungusPenicilliumcrustosumYN-HT-15. Journal of Asian Natural Products Research. 16(3). 285–289. 13 indexed citations

20.

Lu, Xuan, Tian Li, Gang Chen, et al.. (2012). Three new compounds from the marine-derived fungusTrichoderma atrovirideG20-12. Journal of Asian Natural Products Research. 14(7). 647–651. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact